These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
629 related articles for article (PubMed ID: 24728740)
1. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis. Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740 [TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis. Zhu SL; Ke Y; Peng YC; Ma L; Li H; Li LQ; Zhong JH PLoS One; 2014; 9(12):e115834. PubMed ID: 25541684 [TBL] [Abstract][Full Text] [Related]
3. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching. Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976 [TBL] [Abstract][Full Text] [Related]
4. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763 [TBL] [Abstract][Full Text] [Related]
5. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma. Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297 [TBL] [Abstract][Full Text] [Related]
6. Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma. Liu PH; Hsia CY; Lee YH; Hsu CY; Huang YH; Su CW; Lee RC; Lin HC; Huo TI J Surg Oncol; 2015 Mar; 111(4):404-9. PubMed ID: 25643842 [TBL] [Abstract][Full Text] [Related]
7. [Comparison liver resection with transarterial chemoembolization for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma patients on long-term survival after SPSS propensity score matching]. Ke Y; Zhong J; Guo Z; Liang Y; Li L; Xiang B Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):747-50. PubMed ID: 24844957 [TBL] [Abstract][Full Text] [Related]
8. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma. Zhang DZ; Wei XD; Wang XP World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473 [TBL] [Abstract][Full Text] [Related]
9. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis . Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria]. Guo Z; Xiang B; Zhang J; Jiang J; Li L Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1526-9. PubMed ID: 25146737 [TBL] [Abstract][Full Text] [Related]
11. Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching. Min YW; Lee JH; Gwak GY; Paik YH; Lee JH; Rhee PL; Koh KC; Paik SW; Yoo BC; Choi MS J Gastroenterol Hepatol; 2014 May; 29(5):1043-8. PubMed ID: 24863186 [TBL] [Abstract][Full Text] [Related]
12. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis. Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Pai JT; Loong CC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD Ann Surg Oncol; 2012 Mar; 19(3):842-9. PubMed ID: 21913008 [TBL] [Abstract][Full Text] [Related]
13. Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan. Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Itobayashi E; Nouso K; Kariyama K; Ishikawa T; Hirooka M; Hiasa Y Cancer Sci; 2017 Jul; 108(7):1414-1420. PubMed ID: 28406546 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis. Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472 [TBL] [Abstract][Full Text] [Related]
15. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis. Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898 [TBL] [Abstract][Full Text] [Related]
16. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study. Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma. Zhu SL; Zhong JH; Ke Y; Ma L; You XM; Li LQ World J Gastroenterol; 2015 Aug; 21(32):9630-7. PubMed ID: 26327771 [TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis. Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396 [TBL] [Abstract][Full Text] [Related]
19. Role of liver resection in treating intermediate and advanced stage adolescent and young adult hepatocellular carcinoma patients: A propensity-matching cohort study. Zhang W; Liu C; Tan Y; Jiang L; Yan L; Yang J; Wen T Int J Surg; 2018 Jun; 54(Pt A):259-264. PubMed ID: 29602016 [TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma. Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]